Immunogenicity and safety of the new reduced-dose tetanus–diphtheria vaccine in healthy Korean adolescents: A comparative active control, double-blind, randomized, multicenter phase III study
A new reduced-dose tetanus–diphtheria (Td) vaccine was developed in Korea, and phase I and II clinical trials were successfully undertaken. We conducted this double-blind, randomized, multicenter phase III clinical trial to assess the immunogenicity and safety of the new Td vaccine. Methods: Healthy...
|Main Authors:||, , , , , , , , , , , , ,|
|Series:||Journal of Microbiology, Immunology and Infection|